keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CKLF1-C27, a C-terminal peptide of CKLF1, effectively binds to and activates the CCR4 receptor, thereby triggering the ERK1/2 pathway. It competes with CKLF1 for the CCR4 receptor, neutralizing CKLF1's cellular effects. Furthermore, CKLF1-C27 significantly promotes the proliferation of HUVECs and holds promise for psoriasis research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | CKLF1-C27, a C-terminal peptide of CKLF1, effectively binds to and activates the CCR4 receptor, thereby triggering the ERK1/2 pathway. It competes with CKLF1 for the CCR4 receptor, neutralizing CKLF1's cellular effects. Furthermore, CKLF1-C27 significantly promotes the proliferation of HUVECs and holds promise for psoriasis research [1]. |
Molecular Weight | 3196.78 |
Formula | C151H243N39O37 |
CAS No. | 891861-48-6 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CKLF1-C27 891861-48-6 inhibitor inhibit